Return to Trial Database

HCRN-MCC20-443

A Single Arm Phase II Study with Safety Run-in of Peptide Receptor Radionuclide Therapy (PRRT) in Combination with Immunotherapy for Patients with Merkel Cell Cancer (iPRRT Study)

Status

Currently Enrolling

Cancer Type(s)

Merkel Cell Carcinoma

Study Contact

studies@hoosiercancer.org

Trial Locations

All sites in which the trial HCRN-MCC20-443 being conducted in.

University of Iowa Holden Comprehensive Cancer Center

University of Wisconsin Carbone Cancer Center

Weill Cornell Medicine